藥碼
NOV02
藥名
Insulin aspart 100 IU/mL, 3 mL
英文商品名
NovoRapid 胰島素筆 橘
中文商品名
諾和瑞諾易筆
螢幕名
NovoRapid 胰島素筆 橘
劑型
Inj
規格
FlexPen Inj 100 U/mL (pre-filled pen, clear, colorless, aqueous suspension for infection) x 3 mL
成分
藥理分類
Insulins
健保碼
KC00823266
ATC碼
適應症
|
【藥品性質提示】 根據 2019 AGS Beers Criteria，本藥品為【潛在不適當用藥 (PIM)】，不建議單獨用於老年人短期降血糖，應搭配基礎胰島素。 ★LASA藥品：NOV01 30/70 NovoMix 3mL/FlexPen (形似) 點擊看LASA藥品外觀比較圖 #高警訊藥品 【藥品訊息】 NovoRapid 胰島素筆 橘 衛教單張 |
糖尿病 (其他胰島素) Treatment of patients with diabetes mellitus
藥理
Insulin, Rapid-Acting
Insulin acts via specific membrane-bound receptors on target tissues to regulate metabolism of carbohydrate, protein, and fats. Target organs for insulin include the liver, skeletal muscle, and adipose tissue.
Insulin acts via specific membrane-bound receptors on target tissues to regulate metabolism of carbohydrate, protein, and fats. Target organs for insulin include the liver, skeletal muscle, and adipose tissue.
藥動學
1. Onset: 10-20 minutes
2. Peak effect: 1-3 hours
3. Duration: 3-5 hours
2. Peak effect: 1-3 hours
3. Duration: 3-5 hours
禁忌症
1. Hypoglycemia
2. Hypersensitivity to insulin aspart or any of the excipients
2. Hypersensitivity to insulin aspart or any of the excipients
懷孕分類
B
哺乳分類
Compatible
副作用
Hypoglycaemia, Amyloidosis (localized cutaneous at injection site), Lipodystrophy
#仿單變更2022
#仿單變更2022
劑量和給藥方法
Usual initial dose: 0.4-1 unit/kg/day in divided doses; SC within 5-10 min before a meal.
小兒調整劑量
腎功能調整劑量
There are no dosage adjustments provided in manufacturer's labeling; insulin requirements are reduced due to changes in insulin clearance or metabolism
肝功能調整劑量
There are no dosage adjustments provided in manufacturer's labeling; insulin requirements are reduced due to changes in insulin clearance or metabolism
安定性
藥袋資訊
臨床用途
胰島素，治療第一型或第二型糖尿病
主要副作用
低血糖，使用胰島素注射劑請量測血糖並注意血糖值變化。
泡製方法
儲存方式
未使用前請置於 2-8℃ 冷藏儲存，第一次使用後請置於 15-25℃ 保存。請於開封一個月後丟棄。
注意事項
其他說明
門診 X6-2、急首 X2-2 | 藥庫 冰X21
藥品外觀
顏色
形狀
剝痕
標記1
標記2
其他
健保藥價
237
自費價
315.21
仿單
資料庫
健保給付規定